The cancer control community is largely unaware of great advances in the control of major
human cancers with vaccines, including the dramatic control of hepatocellular (liver) cancer …

Human papillomavirus (HPV)-related cancers are a major worldwide public health concern.
Virtually all cervical cancer is HPV related, with 70% caused by HPV16 and-18. Variable …

Globally, human papillomavirus (HPV) infection is one of the most common sexually
transmitted infection. HPV is linked to at least five malignancies including vulvar, vaginal …

Abstract Cervarix® and Gardasil®, 2 human papillomavirus (HPV) vaccines, have been
approved and implemented globally in young adolescent women with the hope of reducing …

Cervical cancer is one of the most common cancers in women aged 15-44 years in the
world, with more than three-quarters of cases diagnosed at a locally advanced clinical stage …

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

Cervical cancer is the second most common female cancer with 500000 new cases and
290000 deaths occurring worldwide per annum. Organized cervical screening programs …

HPV-related diseases represent a major cause of morbidity and mortality, although effective
HPV vaccines are available, potentially allowing for the elimination of these malignancies …

Persistent infection by several microbial agents is responsible for at least 15% of cancer
globally, including most cancers of the liver, stomach, and cervix. The recent development of …

Globally, cervical cancer is second only to breast cancer as the leading cause of cancer in
women, with a global prevalence of 2.3 million. It is the third most common cause of female …